Evaluation of the Effect of HFMT in Promoting Donor-site Wound Healing (NCT05839158) | Clinical Trial Compass
CompletedNot Applicable
Evaluation of the Effect of HFMT in Promoting Donor-site Wound Healing
China100 participantsStarted 2022-03-01
Plain-language summary
Autologous hair transplantation involves follicle extraction, trimming, and implantation. Follicle trimming improves efficiency and postoperative appearance, resulting in the discarded tissue known as hair follicle-derived microtissue (HFMT). In a clinical case, HFMT homogenate was applied to the FUE donor area wound, resulting in reduced pain, relief from itching, and faster healing compared to conventional treatment. This study aims to compare the effects of HFMT on FUE donor area wound healing.
Who can participate
Age range
18 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients aged 18-60 years who underwent FUE autologous hair transplantation.
* The patient's liver and kidney function were normal, and the serum protein level before surgery was normal.
Exclusion Criteria:
* Patients with a history of smoking.
* Those suffering from diseases that affect wound healing, such as diabetes or hyperglycemia.
* Those with abnormal blood sugar.
* Abnormal cardiopulmonary function.
* There are foci of infection in or near the surgical area.
* Scar hyperplasia or scar constitution.
* Those with a history of neuralgia.
* The patient took immunosuppressants, cytostatics, and hormonal anticoagulants before surgery and antibiotics.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Changes in the area of the wound at the donor site
Timeframe: post op days 3, 5, 7, 14 and post op weeks 4, 6, 8, 12, 16, 24
Trial details
NCT IDNCT05839158
SponsorNanfang Hospital, Southern Medical University